This review provides guidance on the perioperative management of patients on anti-platelet and anticoagulant therapy, balancing bleeding and thrombotic risks.
Answers are grounded in this paper and cite their sources.
May guide perioperative antithrombotic decisions; leaves open need for prospective validation of protocols.
Surgeons commonly need to treat patients receiving anticoagulant and anti-platelet therapy. This requires risk assessment and management to balance minimization of bleeding complications and avoidance of further ischaemic or thrombotic events. This review considers the evidence available to guide management of patients on anti-platelet and anticoagulant therapy, including some of the new classes of anti-platelets and anticoagulants which clinicians may be less familiar with.
No takes yet. Share an insight, caveat, or question.
McKenzie et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: